Sera Prognostics, known as The Pregnancy Company, is a leading brand in health diagnostics aimed at improving the lives of women and their babies through prenatal care. Their mission is to deliver essential information to physicians, pregnant women, and healthcare payers to significantly enhance maternal and neonatal health while reducing healthcare costs. One of their key offerings, the PreTRM Test, accurately identifies women at a higher risk for spontaneous preterm birth.

This test predicts an individual's risk of preterm delivery in asymptomatic singleton pregnancies through a simple blood draw performed between weeks 18 and 20 of gestational age. Sera Prognostics is also committed to research and innovation in the field. Their publications confirm the performance of biomarkers and clinical validation of PreTRM®, as well as the health economic analysis supporting the test-and-treat strategy to improve maternal and infant health.

With a focus on personal and professional development, Sera Prognostics encourages growth, making it an ideal company for passionate individuals dedicated to revolutionizing healthcare outcomes for mothers and babies